Martin Shkreli ban from pharmaceutical industry upheld by US court

New York federal appeals court rules ‘pharma bro’, 40, who went to prison for fraud, cannot return to pharmaceutical industry

Martin Shkreli, the “pharma bro” entrepreneur who astronomically increased the price of a life-saving drug by more than 4,000% and became a symbol of corporate Wall Street greed, cannot return to the pharmaceutical industry, a court has ruled.

A federal appeals court in New York upheld his lifetime ban from the business.